ArticlePharmaceutics2022

Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.

Pilar María Luque-Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.